Skip to main content
SpringerLink
Log in

Cytokine profiles in COVID-19 patients undergoing adjunct ozone therapy: some comments

  • Commentary
  • Published:
Inflammopharmacology Aims and scope Submit manuscript

Abstract

A comment to: Ghaleh HEG, Izadi M, Javanbakht M, Ghanei M, Einollahi B, Jafari NJ, Alishiri G, Aslani J, Abolghasemi H, Simonetti V, Khafaei M, Zhao S, Saadat SH, Ahmadi M, Parvin S, Vazifedoust S, Alvanagh AG. Cytokine profile and antioxidants status in the moderate and severe COVID-19 patients: a trial of ozone therapy impact as a medicinal supplement. Inflammopharmacology. 2023 Jul 12. https://doi.org/10.1007/s10787-023-01288-9.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Data availability

Enquiries about data availability should be directed to the authors.

References

  • Carlini V, Noonan DM, Abdalalem E, Goletti D, Sansone C, Calabrone L, Albini A (2023) The multifaceted nature of IL-10: regulation, role in immunological homeostasis and its relevance to cancer, COVID-19 and post-COVID conditions. Front Immunol 8(14):1161067

    Article  Google Scholar 

  • Chirumbolo S, Valdenassi L, Simonetti V, Bertossi D, Ricevuti G, Franzini M, Pandolfi S (2021) Insights on the mechanisms of action of ozone in the medical therapy against COVID-19. Int Immunopharmacol 96:107777

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Fernández-Cuadros ME, Albaladejo-Florín MJ, Peña-Lora D, Álava-Rabasa S, Pérez-Moro OS (2020) Ozone (O3) and SARS-CoV-2: Physiological bases and their therapeutic possibilities according to COVID-19 evolutionary stage. SN Compr Clin Med 2(8):1094–1102

    Article  PubMed  PubMed Central  Google Scholar 

  • Franzini M, Valdenassi L, Ricevuti G, Chirumbolo S, Depfenhart M, Bertossi D, Tirelli U (2020) Oxygen-ozone (O2–O3) immunoceutical therapy for patients with COVID-19. Preliminary Evidence Reported Int Immunopharmacol 88:106879

    Article  CAS  PubMed  Google Scholar 

  • Ghaleh HEG, Izadi M, Javanbakht M, Ghanei M, Einollahi B, Jafari NJ, Alishiri G, Aslani J, Abolghasemi H, Simonetti V, Khafaei M, Zhao S, Saadat SH, Ahmadi M, Parvin S, Vazifedoust S, Alvanagh AG (2023) Cytokine profile and antioxidants status in the moderate and severe COVID-19 patients: a trial of ozone therapy impact as a medicinal supplement. Inflammopharmacology. https://doi.org/10.1007/s10787-023-01288-9

    Article  PubMed  Google Scholar 

  • Han H, Ma Q, Li C, Liu R, Zhao L, Wang W, Zhang P, Liu X, Gao G, Liu F, Jiang Y, Cheng X, Zhu C, Xia Y (2020) Profiling serum cytokines in COVID-19 patients reveals IL-6 and IL-10 are disease severity predictors. Emerg Microbes Infect 9(1):1123–1130

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Hernández A, Viñals M, Isidoro T, Vilás F (2020) Potential Role of Oxygen-Ozone Therapy in Treatment of COVID-19 Pneumonia. Am J Case Rep 17(21):e925849

    Google Scholar 

  • Hsu CG, Chávez CL, Zhang C, Sowden M, Yan C, Berk BC (2022) The lipid peroxidation product 4-hydroxynonenal inhibits NLRP3 inflammasome activation and macrophage pyroptosis. Cell Death Differ 29(9):1790–1803

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Islam H, Chamberlain TC, Mui AL, Little JP (2021) Elevated Interleukin-10 Levels in COVID-19: Potentiation of Pro-Inflammatory Responses or Impaired Anti-Inflammatory Action? Front Immunol 21(12):677008

    Article  Google Scholar 

  • Jafari-Oori M, Vahedian-Azimi A, Ghorbanzadeh K, Sepahvand E, Dehi M, Ebadi A, Izadi M (2022) Efficacy of ozone adjuvant therapy in COVID-19 patients: a meta-analysis study. Front Med (lausanne) 10(9):1037749

    Article  Google Scholar 

  • Lu Q, Zhu Z, Tan C, Zhou H, Hu Y, Shen G, Zhu P, Yang G, Xie X (2021) Changes of serum IL-10, IL-1β, IL-6, MCP-1, TNF-α, IP-10 and IL-4 in COVID-19 patients. Int J Clin Pract 75(9):e14462

    Article  CAS  PubMed  Google Scholar 

  • Mousavizadeh L, Soltani R, Abedini K, Ghasemi S (2022) The relation of the viral structure of SARS-CoV-2, high-risk condition, and plasma levels of IL-4, IL-10, and IL-15 in COVID-19 patients compared to SARS and MERS infections. Curr Mol Med 22(7):584–593

    Article  CAS  PubMed  Google Scholar 

  • Queiroz MAF, Neves PFMD, Lima SS, Lopes JDC, Torres MKDS, Vallinoto IMVC, Bichara CDA, Dos Santos EF, de Brito MTFM, da Silva ALS, Leite MM, da Costa FP, Viana MNDSA, Rodrigues FBB, de Sarges KML, Cantanhede MHD, da Silva R, Bichara CNC, van den Berg AVS, Veríssimo AOL, Carvalho MDS, Henriques DF, Dos Santos CP, Nunes JAL, Costa IB, Viana GMR, Carneiro FRO, Palacios VRDCM, Quaresma JAS, Brasil-Costa I, Dos Santos EJM, Falcão LFM, Vallinoto ACR (2022) Cytokine profiles associated with acute COVID-19 and long COVID-19 syndrome. Front Cell Infect Microbiol 12:922422

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Saha S, Buttari B, Panieri E, Profumo E, Saso L (2020) An overview of Nrf2 signaling pathway and its role in inflammation. Molecules 25(22):5474

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Torres M, Casado G, Vigón L, Rodríguez-Mora S, Mateos E, Ramos-Martín F, López-Wolf D, Sanz-Moreno J, Ryan-Murua P, Taboada-Martínez ML, López-Huertas MR, Cervero M, Coiras M (2022) Multidisciplinary Group of Study of COVID-19 (MGS-COVID); Contributing members of the Multidisciplinary Group of Study of COVID-19 (in alphabetical order). Changes in the immune response against SARS-CoV-2 in individuals with severe COVID-19 treated with high dose of vitamin D. Biomed Pharmacother 150:112965

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Valdenassi L, Franzini M, Ricevuti G, Rinaldi L, Galoforo AC, Tirelli U (2020) Potential mechanisms by which the oxygen-ozone (O2–O3) therapy could contribute to the treatment against the coronavirus COVID-19. Eur Rev Med Pharmacol Sci 24(8):4059–4061

    CAS  PubMed  Google Scholar 

  • Wu J, Tan CS, Yu H, Wang Y, Tian Y, Shao W, Zhang Y, Zhang K, Shao H, Ni G, Shen J, Galoforo AC, Wu Q, Ming D (2020) Recovery of four COVID-19 patients via ozonated autohemotherapy. Innovation (camb) 1(3):100060

    CAS  PubMed  Google Scholar 

  • Zhao Y, Qin L, Zhang P, Li K, Liang L, Sun J, Xu B, Dai Y, Li X, Zhang C, Peng Y, Feng Y, Li A, Hu Z, Xiang H, Ogg G, Ho LP, McMichael A, Jin R, Knight JC, Dong T, Zhang Y (2020) Longitudinal COVID-19 profiling associates IL-1RA and IL-10 with disease severity and RANTES with mild disease. JCI Insight 5(13):e139834

    Article  PubMed  PubMed Central  Google Scholar 

  • Zheng Z, Dong M, Hu K (2020) A preliminary evaluation on the efficacy of ozone therapy in the treatment of COVID-19. J Med Virol 92(11):2348–2350

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Funding

The authors have not disclosed any funding.

Author information

Authors and Affiliations

  1. Department of Engineering for Innovation Medicine, University of Verona, Strada Le Grazie 8, 37134, Verona, Italy

    Salvatore Chirumbolo

  2. Italian Society of Oxygen-Ozone Therapy (SIOOT), Bergamo, Italy

    Sergio Pandolfi, Marianno Franzini & Luigi Valdenassi

Authors
  1. Salvatore Chirumbolo
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Sergio Pandolfi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Marianno Franzini
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Luigi Valdenassi
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Salvatore Chirumbolo.

Ethics declarations

Conflict of interest

The authors state they have no conflict of interest.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Chirumbolo, S., Pandolfi, S., Franzini, M. et al. Cytokine profiles in COVID-19 patients undergoing adjunct ozone therapy: some comments. Inflammopharmacol 31, 3363–3365 (2023). https://doi.org/10.1007/s10787-023-01359-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10787-023-01359-x

Keywords

Search

Navigation